Consider a global pharmaceuticals leader that produces an over-the-counter medication that reduces exam-related anxiety. The product is currently protected by a patent, though similar products are reportedly under development. Two years ago, the firm sold 25 million units of the medication at a price of $10 per package (10 doses). Last year, the firm raised the price to $11 and sold 22 million units. The estimated cost of production is constant at $3 per package. Now consider that the firm's patent expired at the end of last year, and immediately the similar (but differentiated) products are now available to customers. With new competitors in the market, the firm would like to release a collection of advertisements aimed at increasing the sale of its medication. Given that the firm's advertising elasticity of demand (AED) is 0.1608, from the total revenue earned last year, the firm should spend?
Consider a global pharmaceuticals leader that produces an over-the-counter medication that reduces exam-related anxiety. The product is currently protected by a patent, though similar products are reportedly under development. Two years ago, the firm sold 25 million units of the medication at a price of $10 per package (10 doses). Last year, the firm raised the price to $11 and sold 22 million units. The estimated cost of production is constant at $3 per package.
Now consider that the firm's patent expired at the end of last year, and immediately the similar (but differentiated) products are now available to customers. With new competitors in the market, the firm would like to release a collection of advertisements aimed at increasing the sale of its medication.
Given that the firm's advertising elasticity of demand (AED) is 0.1608, from the total revenue earned last year, the firm should spend?
Step by step
Solved in 2 steps